Avalon GloboCare Corp Company
Avalon GloboCare Corp is a clinical-stage CellTech bio-developer dedicated to Advancing and Empowering Innovative and Exosome Technology.
Technology:
CAR-T therapy, Cell therapy, Service
Industry:
Public
Headquarters:
Freehold, New Jersey, United States
Founded Date:
2014-01-01
Employees Number:
1-10
Funding Status:
IPO
Total Funding:
25150000
Estimated Revenue:
$1M to $10M
Last Funding Date:
2019-09-03
Last Funding Type:
Post-IPO Equity
Register and Claim Ownership